Special Authority funding data for lenalidomide (Revlimid)
1 October 2020
Dear [name and contact details redacted]
REQUEST FOR INFORMATION
Thank you for your request dated 10 September 2020 under the Official Information Act 1982 (OIA) for information relating to Special Authority (SA) data for lenalidomide (Revlimid) maintenance. You asked for:
- any numbers on the uptake of lenalidomide for the newly subsidised maintenance indication
Please refer to the table below for the number of approved applications under the new indication ‘maintenance following first-line autologous stem cell transplant (SCT)’ submitted since 1 April 2020 (effective date of new SA indication).
|
Financial Year |
Month Submitted |
Initial application |
Renewal |
|
2020 |
2020-04-01 |
44 |
1 |
|
2020-05-01 |
21 |
2 |
|
|
2020-06-01 |
11 |
0 |
|
|
2021 |
2020-07-01 |
4 |
4 |
|
2020-08-01 |
3 |
2 |
We trust that this information answers your queries. We are making our information more freely available, so we will now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.
Yours sincerely
Rachel Read
Manager, Policy and Government Services